Business · 07/02/2022

FDA Extends Comment Period for Guidance on Device Discontinuance

The Food and Drug Administration (FDA) is extending the comment period for draft guidance on notifying the agency of a permanent device discontinuance or interruption in manufacturing, in response to a request for an extension from interested persons.